Kunstler: Who Will Answer? By James Howard

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 energy_wave #72613
528
Kunstler: Who Will Answer?

By James Howard Kunstler
November 15, 2021

Why on earth would any American with a functioning brain believe what he /she /they is being told by the public health officialdom, the politicians, or the news media? For two years, they have lied to you about everything relating to the Covid-19 virus, including where it came from, how it was developed, who sponsored its development, how the vaccines happened to come onstage thirty seconds after the disease entered the scene, how well the vaccines worked, how safe the vaccines were, and whether there were other cheap and effective treatments for the disease.

So, here we are with nearly 200-million Americans fully vaccinated (and 230-million with at least one dose), plus 47-million overall officially registered cases of Covid illness (conferring immunity among the survivors), plus X-number people infected with no symptoms, or people who didn’t get tested when sick, or didn’t bother going to see a doctor or report to a hospital, plus X-number of people with natural immunity to Covid for one reason or another (maybe a high number, based on the Diamond Princess cruise ship ratio of a Pareto-type 80 / 20 distribution) — and now, in the fall of 2021, here comes another surge of Covid-19 among both the vaxxed and un-vaxxed.

Did all that vaxxing help? It apparently did nothing to prevent transmission of the disease. The vaxxed were spreading it as effectively as the unvaxxed, and the vaxxed were catching the disease as easily, too, though supposedly suffering not as badly as the unvaxxed (if you choose to believe the official press releases, and why would you believe them?). Then, along came the reports of “adverse reactions” to the vaccines, many of them quite grave — clots, strokes, infarctions, neurological havoc, organ failure. In mid-October this year, the VAERS registry had it at 17,000 deaths and 26,000 permanent disabilities, and the rule-of-thumb was that these represented only 10 percent of the actual number of adverse events because the VAERS website was so badly designed that it crashed half the time any doctor tried to use it… plus the doctors were being silenced and punished for voicing any distrust of the vaccines.

Then why the mad rush to vaccinate all the children in America? There have been next-to-zero covid deaths among children besides a few hundred with grave co-morbidities like cancer or cystic fibrosis — and the hospitals had a cash subsidy incentive from the federal government to list them as dying “with Covid.” Children are far more likely to suffer harm from the vaccines than from the Covid-19 disease. The child vax experiment is only just underway, and there are already enough cases of myocarditis and other disorders to be very concerned. The medical establishment has no idea what the long-term effects on children might be, in particular on their reproductive systems, since the chief active ingredient in the vaccines, the spike protein, has a proclivity for the sexual organs. It happens, too, by the way, that mothers who got vaxxed in early 2021 are just now giving birth to babies with myocarditis and other signature disorders of adverse mRNA vaccine reactions. Keep your eye on that sub-plot of the story.

One wonders: is this child vax campaign an attempt to eliminate the last major control group in the population? (Or just to eliminate a big demographic chunk altogether?) Is it tied in some way to beating the release date for Pfizer’s “Comirnaty” vaccine — which would vacate the Emergency Use Authorization (EUA) that protects the pharma companies from liability? Despite delirious propaganda from the likes of National Public Radio, the bad news is out, and the bad news is that the Covid vaccines for children are bad news. Parents ought to object to any official attempts to coerce them into vaxxing their kids, but will they? I’d guess that the reaction will be ferocious. Stand by on that.

Meanwhile, what would be an intelligent response to Covid-19 at this point? Well, how about letting it burn through the population as expeditiously as possible, along with an aggressive nationwide early treatment program using existing effective drugs such as ivermectin, hydroxychloroquine, fluvoxamine, budesonide, monoclonal antibodies, for starters, along with vitamin D3, quercetin, zinc, selenium, N-acetyl L-cysteine (NAC)? That would minimize fatalities and confer superior natural immunity throughout the whole population.

Of course, one of the whopper lies you’re being told is that this early treatment protocol doesn’t work. Dozens of clinical studies in other countries and direct clinical experience in this country tell the opposite story: the early treatment protocols work remarkably well. The big question, eventually, will be: who might be held responsible in the public health and medical bureaucracies for militating against early treatment? Was it sheer epic incompetence, or something more malevolent?

https://kunstler.com/clusterfuck-nation/who-will-answer/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Features of the New HONOR Watch 5 Ultra

Updated Category News Views 404

Introducing the HONOR Watch 5 Ultra Global technology leader HONOR has unveiled its latest innovation, the HONOR Watch 5 Ultra, during a major tech event. This smartwatch marks a significant shift for the brand, highlighting its goals to expand beyond smartphones into a holistic AI device ecosystem. Emphasis on Consumer-Centric Technology HONOR is shifting its focus...

Continue Reading
Exploring MEXC's Explosive Token Growth and Trading Insights

Updated Category News Views 217

MEXC's Remarkable Token Performance MEXC, a prominent cryptocurrency exchange, has reported exceptional growth within its trading platform. The exchange highlights significant milestones and valuable market insights driven by the latest developments in the crypto ecosystem. In the past month, particularly notable has been the performance of newly listed tokens,...

Continue Reading
Understanding the Impacts of Dealing Disclosure at Life Science REIT Plc

Updated Category News Views 142

Overview of Disclosure in Finance The realm of finance is continuously guided by various regulations and codes to ensure that all market participants have access to transparent and accurate information. One such crucial regulation is Rule 8 of the Takeover Code. This rule mandates that any person with more than a certain percentage of interest in relevant securities...

Continue Reading
PMGC Holdings Inc. Enhances Business Alignment with New Names

Updated Category News Views 156

PMGC Holdings Announces Exciting Name Changes PMGC Holdings Inc., previously known as Elevai Labs Inc., has embarked on a new chapter with the recent renaming of its subsidiaries. This strategic decision reflects the company’s commitment to better align its operations with its diversified business goals. The name changes will reinforce PMGC's vision as a...

Continue Reading
Analysis of S&P 500 E-Mini Futures: Bulls vs. Bears Strategies

Updated Category News Views 107

Market Overview: S&P 500 E-mini Futures The current trading atmosphere for the S&P 500 E-mini futures is captivating, showcasing intricate movements where bulls strive for a significant breakout, while bears seek to establish solid selling positions. Observations from the recent weekly charts indicate that bears require a robust entry point, ideally with a bearish bar...

Continue Reading